INTRODUCTION
Diabetes mellitus is a chronic disease condition characterized by hyperglycemia, that is associated with high morbidity and mortality from its complications which if uncontrolled leads to various short terms and long-term complications. Diabetes mellitus with its associated complications such as cardiovascular diseases, retinopathy, nephropathy, and neuropathy is a serious health problem 1, 2 . Type 2 Diabetes mellitus account for 90-95% of those with Diabetes mellitus The prevalence rate of Type 2 Diabetes mellitus is high in India and is expected to rise. This rise is due to low literacy rate, lack of public awareness, lack of advanced healthcare facilities and sedentary lifestyle. 3, 4 in this study also the high prevalence rate of type2 diabetes in Dhule Maharashtra due to low literacy rate, lack of public awareness, lack of advanced healthcare facilities and inactive lifestyle. The contribution of pharmacists in diabetes management is so far not documented in India. 5 
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The complication danger is directly related to high blood glucose levels. 3, 5 however, as most patients with type 2 diabetes mellitus have a combination of risk factors together with obesity, hypertension, and hyperlipidemia 4 . The result of the Diabetes Control and Complication Trials 8 and the United Kingdom Prospective Diabetes study 8, 9 The critical issues for managing of diabetes are patient's adherence to exacting dietary, exercise, self care actions, and medication regimens. The greater the number of medications, the more drug related problems such as adverse drug reaction, drug interaction, medication non-adherence, no valid medical indication, and so on. 8, 9 Poor medication adherence seems to be a significant barrier to the accomplishment of positive clinical outcomes among type 2 diabetes patients in both developed and developing countries. 9 Increased pharmaceutical compliance was associated with fewer emergency department visit and patient admissions. Increased medication adherence was associated with decreased medical care cost. 10 in recent years; pharmacists in many practice settings have begun providing patient centered services with the goal of improving drug therapy outcomes through practices such as pharmaceutical care. These PC programs have been found useful in improving the quality of care of patients with various diseases. Pharmacist's interventions in diabetes have also resulted in beneficial outcomes. 11, 12, 15 This study intended to address this gap. Diabetes is a disease that needs more pharmacist involvement. Pharmacists possibly will contribute to such programs through pharmaceutical care. This Pharmaceutical care study will improve the quality of life,health-related quality of life. Pharmaceutical care decreases the fasting plasma glucose, Glycosylated hemoglobin (HbA1c) and Body mass index (BMI). Pharmaceutical care is the straight, responsible situation of medication-related care with the purpose of achieving definite outcomes that improve a patient's quality of life in Type 2 Diabetes mellitus. The generally Pharmaceutical care program improves patients' outcomes, reduce cost, and promote patients quality of life.
MATERIALS & METHODS

Study design:
The study was a prospective, open label and randomized control. It was conducted at SBHGM College, Civil hospital in Dhule Maharashtra. In this study, patients were divided into two groups by simple randomization technique; the first group is control group who only received only medical care, while the second one is intervention group, who received pharmaceutical care. The intervention group was followed up for 3 visits. The interval between each visit ranged from 8-9 weeks with for the follow up. Data Collection: The following data of each patient were recorded in the patient data collection forms (Patient Proforma). 
Study population:
Ethical Consideration
The protocol of study approved from Institutional Human ethical Committee of SBHMG civil hospital Dhule Maharashtra. clearance was obtained from the Ethical Committee. The study aim & objectives were explained to the patients and informed written consent was obtained in local language from them before the data collection.
Study materials:
Patient data collection Form "As per standard guidelines, Patient data collection Form was set and got approval from diabetologist for composed patient data and Pharmaceutical care issues". The form which contain demographic data like Name, file number, weight, height, address, telephone number age, sex, social history, Medical Data Family history of diabetes, food or drug allergies, past medical history, past medication history, hypertension and hyperlipidemia , current treatment regimen, change of prescription drugs and current status of blood glucose level. Process evaluation data Drug therapy problems and adherence by pill count and Morisky-Green test that consists of the following questions. 18ʻʻ Do you ever forget to get your medicine, "Are you careless at times about taking your medicine, "When you experience better, do you sometimes stop taking your medicine, Sometimes if you feel worse when you take the medicine, do you stop taking it.
Clinical outcome data
Data and statistical analysis
The data were entered into a Microsoft Excel Spreadsheet, after data cleanout the data were transported into SPSS.Statistical Package for the Social Sciences-version 1.6 package software program for statistical analysis. 13 Descriptive statistics (numbers and percentage) were calculated for all variables, as well as analytical statistics was done to find the relations between variables.
RESULTS
A total 223 patients were involved in the study out of which 23 patients didn't complete study Out of 223 patients, these patients were distributed into different two such as control group I (n-100) without pharmaceutical care program and Pharmaceutical care program (intervention) groupII (n-100). there were 200 patients who completed the study. The other 23patients
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[225] CODEN (USA): JDDTAO were excluded because they came too late after first or second visits. All patients were counseled after the selection into the study regarding Disease information, medication, diet, exercise and personal hygiene and motivate to improve life style modification. All patients baseline parameter were recorded before the pharmaceutical care program counseling as control values and recorded at each follow up. Demographic characteristics of patients As Shown in Table 1 . The baseline value of FPG of Group-I was 213.6± 42.87and it no reduced significantly 220.0± 43.18after 6 month. The baseline value of FPG Group-II of was 201 ± 41.40 and it reduced significantly upto 160± 0.8after 6 month.. There were statistical significant differences in FPG found only in intervention Group-II. P-value < 0.05 considered as statistical significant differences. Shown in Table No 2. Effect of pharmaceutical care program on glycosylated hemoglobin: (Given in Table No. 2)
The statistical significant difference reductions in the glycosylated hemoglobin level were observed among in intervention Group-II. The HbA1c was found to be reduced more significantly in group II patients from 9.41 ± 1.06 to 8.23 ± 0.85. P-value < 0.05 considered as statistical significant differences .shown in Table No Effect of pharmaceutical care program on BMI: (Given in Table No. 2)
The baseline values of BMI of G-I and Group-II were 26±2.9, 26± 3.1 after 6 month final values BMI of G-I and Group-II were 26 ± 2.9, 24 ± 1.8 There were statistical significant differences in BMI found only in intervention Group-II. P-value < 0.05 considered as statistical significant differences shown in Table No Values are expressed as Mean ± SD (n=100 for each group) P-value < 0.05 considered as statistical significant differences Medication Adherence There are many methods for the assessment of medication compliance. In this study, indirect methods have been used (interview and pill count technique) for the evaluation of Adherence among patients in the intervention group. Medication Adherence from the first visit until the end of the study is summary in Table 3 . 
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DISCUSSION
Pharmacist is main part in a health care team. This team normally consists of pharmacist, physician, nurse, technician, and other health care professions. All of the members in health care team have important roles in diabetes management in accomplishing the goal of treatment, improving quality of life, controlling disease and its complications, detaining complication, and decreasing mortality and morbidity. 1, 4, 5 In this present study pharmacist is main role in pharmaceutical care program Pharmacists' interventions are an important factor to improve glycemic control in diabetic type2 patients. Pharmacists' interventions include diabetes education and counseling on disease, drug, diet, exercise, life style modification, and self management, identifying and solving drug-related problems, improving glycemic control, more recent studies, all these interventions used in present study. HbA1c levels, Fasting Blood Glucose levels and Body Mass Index values significantly reduced with pharmacists' interventions compared with usual care.
14 Mean difference in the change of HbA1c, FPG and BMI This would help patients meeting the target of their treatment. In This present study significant fall in the values of HbA1c, FPG and BMI in the intervention group II as compared to control groupI.differences is 1.18±0.75, 41±14.97, & 2.13 respectively. The data analysis showed there were significant reductions in FPG, HbA1c, and BMI (160± 0.8mg/dl, 8.23 ± 0.85%.and 24 ± 1.8kg/m 2 respectively) obtained in the intervention group at the end of the study period. But there is no significant FPG, HbA1c, and BMI reduction in the control group. Our result complied with those of other similar studies. 13 The pharmacist's interventions in more recent studies also resulted in beneficial outcomes. In the study 14, 15 studied the quality of care of a pharmacist-managed diabetes clinic. This inconsistent result could be explained by various reasons, for example: noncompliance to dietary control and exercise might explain this result. 15 reported that poor compliance to dietary recommendations, missed appointment, and medication noncompliance were found in 56.69%, 13.33% and 5.55% of patients, respectively vast numbers of the diabetic patients suffer from poor dietary control. these may suggest that diabetic patients may need dietary modification specialists to assist them. 18 The present study shows that better pharmacist education sessions, pill count, use of dietary chart and follow up calls and activities prove beneficial in falling mean FPG and HbA1cs significantly. To our knowledge, this type of intervention is first of its kind to be reported in Dhule Maharashtra region and shows that pharmacists could have added significance in "diabetes care management" through pharmaceutical care program. 18 At the third visit, compliance rate was assessed by Morisky-Green test and pill count technique, the number of non-adherence patients was reduced to 15(19%) patients. 17, 18 Our results show that the major cause of non-adherence is forgetting to take medications (at the end of the study), the reasons of forgetting to take medications were mainly due to forgetfulness, being too busy, hard working and uneducated.These causes may be solved if patients educate the importance of taking medicine at correct time and punctuality. This study disclosed that, the pharmacist may play an important role to teach patients about diabetic drugs and disease, to reduce the rate of non-adherence among diabetic patients.
Drug Therapy Problems: Drug therapy problems (DTPs) were adapted from the definition of Cipolle and strand and it was classified into four categories indication, efficacy, safety and non-adherence. 5, 10 In this study, the non-adherence problems were the highest among DTPs. During the 2nd and 3rd visits for the intervention group, the intervention was accepted and the DTPs was solved in 98 cases (231 cases of DTP were not solved) and DTPs was solved in 17 cases (13 cases of DTP were not solved), respectively.
CONCLUSION
In this study result showed that there are significant reductions in glycemic levels i.e. FPG, HbA1C and BMI for the intervention group this result recommended that, the implementation of the pharmaceutical care program might result in good Glycemic control compared to usual medical care. In term of medication adherence, this study showed that, pharmaceutical care program can increase the rate of medication adherence among patients in the intervention group. Drug therapy problem is also one of the important objectives for this study, the study findings showed that the numbers of patients who do not have any DTPs from the 1st visit to the 3rd are significantly improved. In This present study we conclude that Pharmaceutical care program study will improve the quality of life, "health-related quality of life". The study, therefore, recommended that the pharmaceutical care program on the total care of the patients should be established in all chronic disease. The Pharmaceutical Care provided by the pharmacist to the type 2 diabetic patients was effective in reducing the blood glucose levels and in improving their overall quality of life.
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